EICHOR
● Active Not Recruiting
Avacostar - (PASS)
Condition: ANCA-associated Vasculitis · Sponsor: Vifor Fresenius Medical Care Renal Pharma
About this study
The Avacostar PASS is a non-interventional, multi-national, prospective cohort study that will collect data from 2 cohorts of patients: those treated with avacopan for active severe AAV, and a second cohort treated with a cyclophosphamide or rituximab-based induction regimen without avacopan for active severe AAV. The overall study duration is anticipated to be up to 7 years, including a recruitment period of approximately 3 years.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (35)
| Charité University Medicine | Berlin, Germany | — |
| University Hospital of Cologne | Cologne, Germany | — |
| Municipal Hospital Dresden | Dresden, Germany | — |
| University Hospital Essen | Essen, Germany | — |
| University Hospital Freiburg | Freiburg im Breisgau, Germany | — |
| University Medical Center Göttingen | Göttingen, Germany | — |
| University Hospital Eppendorf | Hamburg, Germany | — |
| KRH Klinikum Siloah | Hanover, Germany | — |
| Rheumazentrum Ruhrgebiet | Herne, Germany | — |
| LMU | Munich, Germany | — |
| Medius Kliniken | Plochingen, Germany | — |
| St. Josef-Stift Sendenhorst | Sendenhorst, Germany | — |
+ 23 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05897684